Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research

This study found regional differences in diagnosing and treating testosterone deficiency

Louis J. Gooren

2007

Scholarcy highlights

  • This study analysed the potential variations between different countries in different regions of the world in diagnosing and treating testosterone deficiency
  • While T continues to be contraindicated in men with prostate cancer and breast cancer, current literature does not provide any evidence of a cause-effect relationship between endogenous T or T treatment and prostate cancer development
  • Of the patients seen by the selected physicians, an average of 8% suffered from testosterone deficiency
  • Most men diagnosed with testosterone deficiency were >45 years of age
  • This study found regional differences in diagnosing and treating testosterone deficiency
  • Published online: So, while concerns about potential side-effects of T administration were pervasive, physicians thought that T administration would have a beneficial effect on a patient's quality of life, improvement of libido and that proven T deficiency would constitute a good reason to start T treatment
  • Physicians need to be updated on the role of testosterone in erectile dysfunction as well as on properly diagnosing testosterone deficiency
  • They must acquire new insights in the ramifications of testosterone deficiency on general health in elderly men

Need more features? Save interactive summary cards to your Scholarcy Library.